Nav: Home

Elsevier announces the launch of Kidney International Reports

June 15, 2016

Philadelphia, PA, June 15, 2016 - Elsevier, a world-leading provider of scientific, technical, and medical information products and services, and the International Society of Nephrology (ISN), the global medical society devoted to advancing kidney care worldwide, today announced the launch of Kidney International Reports (KI Reports). This new bi-monthly, open access journal will publish leading research and developments related to kidney disease.

Led by Editor-in-Chief Jai Radhakrishnan, MD, MS, and an editorial board of experts in the field, KI Reports is designed to be both a forum and a learning center for the improved care of patients with kidney disease. The journal will publish original clinical and select translational articles, as well as other educational content related to the pathogenesis, evaluation, and management of acute and chronic kidney disease, end stage renal disease (including transplantation), acid-base, fluid and electrolyte disturbances, and hypertension.

Discussing the new journal, Dr. Radhakrishnan commented, "With the launch of KI Reports, the nephrology community will benefit from prompt peer review and immediate access to the most important clinical and translational research in the field, with the added benefit of Elsevier's world-class publishing platforms."

KI Reports is currently accepting submissions. The journal will publish original research articles, brief reports, research letters, and case reports, as well as editorials and narrative reviews on recent developments in the literature. Of particular interest are submissions related to clinical trials, epidemiology, systematic reviews (including meta-analyses) and outcomes research. The journal will also provide a platform for wider dissemination of national and regional guidelines and consensus meeting reports. While maintaining a rigorous peer review process, KI Reports will use innovative technology to provide authors novel means to share findings and data with readers in a timely manner. Authors publishing in KI Reports will benefit from rapid peer-review and their papers will be available open access on http://www.kireports.org and on ScienceDirect.

Sarah Pratta, Executive Publisher at Elsevier, commented, "The launch of KI Reports responds to the growing demand from our authors for more publishing outlets in nephrology. As publisher of the International Society of Nephrology's journals, including Kidney International, we are confident of KI Reports' success."
-end-
About the International Society of Nephrology

Established in 1960, the International Society of Nephrology (ISN) is a not-for-profit society whose mission is the global advancement of nephrology. The ISN is dedicated to advancing the diagnosis, treatment, and prevention of kidney diseases in developed and emerging countries by raising public awareness of the importance of early recognition and treatment of kidney diseases; connecting professionals interested in kidney and related diseases around the world; supporting research to achieve optimal care of people with kidney diseases; providing nephrology education and training worldwide; and, ultimately, reducing the frequency and impact of kidney diseases and their associated conditions. For more information, visit http://www.theisn.org.

About open access publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 500 open access journals, and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research, but that it is factual, original, and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com

Media contact

Sarah Pratta
Elsevier
+1 215 239 3798
s.pratta@elsevier.com

Elsevier

Related Kidney Disease Articles:

Combating chronic kidney disease with exercise
A University of Delaware research team is combating chronic kidney disease (CKD) with exercise.
A new mutation in kidney disease
Osaka University researchers find an unexpected mutation in proteins of the exosome could be a valuable biomarker for diagnosing the risk of kidney disease.
New answers for kids with inherited kidney disease
A new gene behind a rare form of inherited childhood kidney disease has been identified by a global research team.
Revealed: The biochemical pathways of kidney disease
In a study, recently published in PLOS Genetics, Chiara Gamberi and her coauthors developed an innovative fruit fly-based model of the types of harmful cysts that can form on kidneys.
Forging new defenses against diabetic kidney disease
Scientists at Joslin Diabetes Center have revealed an unexpected route to slow the progression of diabetic kidney disease, targeting a biological pathway that is the main channel for the metabolism of glucose in the cell.
Kidney disease is a major cause of cardiovascular deaths
In 2013, reduced kidney function was associated with 4 percent of deaths worldwide, or 2.2 million deaths.
A kidney disease's genetic clues are uncovered
Researchers at Columbia University Medical Center have identified genes that are linked to the underlying molecular defect in people with IgA nephropathy, an autoimmune kidney disease.
Beating kidney disease together
Chronic kidney disease is a frequently encountered disorder: more than 10% of the population suffer from such problems.
Reflux and ulcer medications linked to kidney stones and chronic kidney disease
Individuals who took proton pump inhibitors or histamine receptor-2 blockers for heartburn, acid reflux, or ulcers had elevated risks of developing kidney stones.
Method to create kidney organoids from patient cells provides insights on kidney disease
Scientists have developed a method to coax human pluripotent stem cells to mature into cells that go on to form the functional units of the kidney.

Related Kidney Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...